TP53 and neoplasm: Tumor suppressor gene therapy transfects p53 gene. Restoring p53 function by SGT-53 boosts antitumor immunity, augments anti-PD1 therapy, sensitizes tumors otherwise insensitive to anti-PD1 immunotherapy and reduces immune-related adverse events [39].